1	Suppression	suppression	_	_	_	_	_	_	_
2	by	by	_	_	_	_	_	_	_
3	azelastine	azelastine	_	_	_	_	_	_	_
4	hydrochloride	hydrochloride	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	involved	involve	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	generation	generation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	cytokines	cytokine	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	nitric	nitric	_	_	_	_	_	_	_
16	oxide	oxide	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	influence	influence	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	anti-allergy	anti-allergy	_	_	_	_	_	_	_
6	agent	agent	_	_	_	_	_	_	_
7	azelastine	azelastine	_	_	_	_	_	_	_
8	hydrochloride	hydrochloride	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	Azeptin	Azeptin	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	associated	associate	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	generation	generation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	cytokines	cytokine	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	nitric	nitric	_	_	_	_	_	_	_
24	oxide	oxide	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	NO	no	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	was	be	_	_	_	_	_	_	_
29	investigated	investigate	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	various	various	_	_	_	_	_	_	_
32	kinds	kind	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	human	human	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	mouse	mouse	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Azeptin	Azeptin	_	_	_	_	_	_	_
2	dose-dependently	dose-dependently	_	_	_	_	_	_	_
3	suppressed	suppress	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	DNA	dna	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	protein	protein	_	_	_	_	_	_	_
8	synthesis	synthesis	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	gingival	gingival	_	_	_	_	_	_	_
12	fibroblasts	fibroblast	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	HF	HF	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	also	also	_	_	_	_	_	_	_
18	suppressed	suppress	_	_	_	_	_	_	_
19	blastogenesis	blastogenesis	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	peripheral	peripheral	_	_	_	_	_	_	_
23	blood	blood	_	_	_	_	_	_	_
24	lymphocytes	lymphocyte	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	PBL	PBL	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Generation	Generation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	tumor	tumor	_	_	_	_	_	_	_
4	necrosis	necrosis	_	_	_	_	_	_	_
5	factor-alpha	factor-alpha	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	interleukin	interleukin	_	_	_	_	_	_	_
8	1-beta	1-beta	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
11	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	interleukin-6	interleukin-6	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	10(-5)	10(-5)	_	_	_	_	_	_	_
17	M	M	_	_	_	_	_	_	_
18	Azeptin-treated	azeptin-treated	_	_	_	_	_	_	_
19	PBL	pbl	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	monocytes	monocyte	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	HM	HM	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	was	be	_	_	_	_	_	_	_
27	decreased	decrease	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	approximately	approximately	_	_	_	_	_	_	_
30	1/3	1/3	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	2/3	2/3	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	control	control	_	_	_	_	_	_	_
36	levels	level	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	parallel	parallel	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	decreased	decrease	_	_	_	_	_	_	_
6	cytokine	cytokine	_	_	_	_	_	_	_
7	generation	generation	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	each	each	_	_	_	_	_	_	_
10	cytokine	cytokine	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	less	less	_	_	_	_	_	_	_
14	expressed	express	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	presence	presence	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	10(-5)	10(-5)	_	_	_	_	_	_	_
20	M	M	_	_	_	_	_	_	_
21	Azeptin	Azeptin	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	inducible	inducible	_	_	_	_	_	_	_
6	nitric	nitric	_	_	_	_	_	_	_
7	oxide	oxide	_	_	_	_	_	_	_
8	synthase-mRNA	synthase-mrna	_	_	_	_	_	_	_
9	level	level	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	NO	no	_	_	_	_	_	_	_
12	generation	generation	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	mouse	mouse	_	_	_	_	_	_	_
15	peritoneal	peritoneal	_	_	_	_	_	_	_
16	macrophages	macrophage	_	_	_	_	_	_	_
17	were	be	_	_	_	_	_	_	_
18	suppressed	suppress	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	10(-5)	10(-5)	_	_	_	_	_	_	_
21	M	M	_	_	_	_	_	_	_
22	Azeptin	Azeptin	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Being	be	_	_	_	_	_	_	_
2	compatible	compatible	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	those	those	_	_	_	_	_	_	_
5	results	result	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	Azeptin	Azeptin	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	10(-5)	10(-5)	_	_	_	_	_	_	_
10	M	M	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	suppressed	suppress	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	PBL	PBL	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	HM	HM	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	HF	HF	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	appear	appear	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	indicate	indicate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	suppression	suppression	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	cytokine	cytokine	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	NO	no	_	_	_	_	_	_	_
12	generation	generation	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	Azeptin	Azeptin	_	_	_	_	_	_	_
15	results	result	_	_	_	_	_	_	_
16	at	at	_	_	_	_	_	_	_
17	least	least	_	_	_	_	_	_	_
18	partially	partially	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	inhibition	inhibition	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	NF-kappa	NF-kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	activation	activation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

